SEC
SlamSEC
SearchBrowseEarnings

Nautilus Biotechnology, Inc.

Nasdaq:NAUT
Laboratory Analytical Instruments·SEATTLE, WA
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Summary Financials

A nautilus is any of the various species within the cephalopod family Nautilidae. This is the sole extant family of the infraorder Nautilaceae and the suborder Nautilina.

CEO
Patel Sujal M
CFO
Mowry Anna
Revenue
—
Adj. EBITDA
$1.4M
FY 2020
Net Income
-$70.8M
FY 2025
EPS (Diluted)
-$0.56
FY 2025
Stock Price
$2.42
-0.4%
2026-03-11
52W Range
$0.62 – $3.08
P/E Ratio
-4.3x
Market Cap
$306.3M
Cash
$27.6M
FY 2025
Total Debt
—
Net Cash
$27.6M
Enterprise Value
$278.6M
Debt / EBITDA
-19.4x
FY 2025
EV / EBITDA
195.7x
Employees
—